The UK has a world-leading research ecosystem for medicines discovery research, which is supported by a multitude of translational infrastructure and targeted funding streams for early-stage clinical research. However, in order to maintain and improve upon this excellence, we need to embrace new...
Following the publication of ‘Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study’, the Association of the British Pharmaceutical Industry has issued the following statement.
Last week, researchers, funders and clinicians celebrated International Clinical Trials Day. It’s been 269 years since James Lind performed his now famous first ever clinical trial looking at treatments for scurvy. But fast forward almost 270 years and clinical trials are more complex than ever...
“I won’t rest until we manage to deliver solutions that make blood cancer a manageable or even curable condition.” - Dr Catherine Taylor, Therapy Area Lead; Haemotology; Janssen Oncology; Europe, Middle East, Africa.
Have you ever wondered if the scientists you see in movies that are racing against the clock to prevent a deadly disease breakout actually exist?
Following the European Union's (EU) General Affairs Council decision to select Amsterdam, The Netherlands as the new location for the European Medicines Agency (EMA), the Association of the British Pharmaceutical Industry (ABPI) – the trade group for the pharmaceutical industry in the UK – have...
The Association of the British Pharmaceutical Industry (ABPI) have responded to a new study, published today in the British Medical Journal (BMJ), that suggests that clinical trials which are financially linked to the pharmaceutical industry have a ‘bias in the evidence base’.
Pharmaceutical companies are showing a ‘significant trend’ towards increased clinical trial transparency according to a new ABPI study published in the peer-review journal Current Medical Research and Opinion (CMRO).
"Today has seen the publication of Clinical Trials in the United Kingdom from the Department of Health, a report providing an overview of progress being made by the UK and the National Institute for Health Research (NIHR) in England to make the UK a premier destination for clinical trials."
“The ABPI would like to express our deepest sympathy with regards to the tragic incident in France and our thoughts are with the individuals and their families."